BioPharmSignal logoBioPharmSignal

Biotech News

Lyell Immunopharma Announces Participation in May Investor Conferences

Lyell Immunopharma (LYEL)Lyell ImmunopharmaCompany update

SOUTH SAN FRANCISCO, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today announced that members of its senior

Open original release

Related news

LYELLyell Immunopharma2026-06-01 12:00 EST

Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026

LYELLyell Immunopharma2026-05-06 20:05 EST

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026

SNDXSyndax Pharmaceuticals2026-05-20 11:00 EST

Syndax Announces Participation in Upcoming Investor Conferences

EXELExelixis2026-05-07 20:05 EST

Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May

KYMRKymera2026-05-06 11:00 EST

Kymera Therapeutics to Participate in Upcoming May Investor Conferences

RLAYRelay Therapeutics2026-05-27 20:05 EST

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June

EXELExelixis2026-05-27 20:05 EST

Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in June

ARGXArgenx2026-05-27 05:00 EST

argenx to Present at Upcoming Investor Conferences

ELVNEnliven Therapeutics2026-05-21 20:05 EST

Enliven Therapeutics to Present at Upcoming Investor Conferences

ZNTLZentalis2026-05-13 20:05 EST

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

View all latest news

Lyell Immunopharma

Lyell Immunopharma is a cell-therapy company focused on reprogramming T cells for durable cancer treatment. Its work centers on improving persistence and potency in cellular immunotherapy.

Recent company news

LYELLyell Immunopharma2026-06-01 12:00 EST

Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026

LYELLyell Immunopharma2026-05-12 12:00 EST

Lyell Immunopharma Announces Participation in May Investor Conferences

LYELLyell Immunopharma2026-05-06 20:05 EST

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026

LYELLyell Immunopharma2026-04-07 12:00 EST

Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference

LYELLyell Immunopharma2026-03-12 20:05 EST

Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results

Stock data

Close
12.96 USD
Market cap
347.44M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States